Zacks Small Cap Research on MSN21m
AEMD: Oncology Trial Moves Forward as Patient Enrollments Begin, Positive on Cost Containment MeasuresAEMD READ THE FULL AEMD RESEARCH REPORT Patient enrollments begin for AEMD’s basket oncology trial Aethlon Medical (NASDAQ:AEMD) announced FY 2Q results and provided a business update yesterday. The ...
The solution aims to streamline provider workflows while enhancing outcomes for breast cancer patients and empowers ...
and Dean for Oncology in the Biological Sciences Division. “Patients with cancer don’t have time to wait for new treatments, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback